ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 072,96
0,45%
DAX
17 896,50
-0,14%
Brent Oil
83,53
-0,01%
Bitcoin
59 045,97
1,39%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ligand Pharmaceuticals Incorporated (LGND)

  7. Ligand Pharmaceuticals Incorporated (LGND) Actualités

LGND Ligand Pharmaceuticals Incorporated

71,78
0,36 (0,50%)
Dernière mise à jour : 18:36:08
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,36 0,50% 71,78 18:36:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
71,77 70,855 72,70 71,42
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/3/202419:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:12EDGAR2Form 144 - Report of proposed sale of securities
01/3/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:49EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
29/2/202400:05EDGAR2Form 144 - Report of proposed sale of securities
28/2/202423:43EDGAR2Form 144 - Report of proposed sale of securities
27/2/202413:24EDGAR2Form 8-K - Current report
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202412:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202421:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202401:30GLOBEHenlius and Sermonix Announce Strategic Collaboration and..
05/1/202423:40DJNLigand Pharmaceuticals Gets FDA OK for Viral Skin Infection..
04/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202321:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202321:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:25EDGAR2Form 8-K - Current report
01/12/202314:20GLOBEPalvella Therapeutics and Ligand Pharmaceuticals Expand..
28/11/202315:01GLOBESermonix Pharmaceuticals Announces Five Abstracts Accepted..
10/11/202303:48EDGAR2Form 8-K/A - Current report: [Amend]
09/11/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:08EDGAR2Form 8-K - Current report
06/11/202315:00GLOBESermonix Pharmaceuticals Announces JCO Precision Oncology..
18/10/202315:03EDGAR2Form 8-K - Current report
18/10/202314:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
03/10/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:00GLOBESermonix Pharmaceuticals Shares Results of EQUALS 2 Survey..
27/9/202314:38EDGAR2Form 8-K - Current report
26/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202323:26EDGAR2Form 8-K - Current report
14/8/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:02EDGAR2Form 8-K - Current report
17/7/202314:45GLOBENovan Enters into Agreement to Sell Substantially All of its..
11/7/202300:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202300:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202315:00GLOBESermonix Pharmaceuticals to Present Two Posters at The..
05/6/202315:01GLOBESermonix Pharmaceuticals Shares ASCO Poster Presentation on..
25/5/202323:00GLOBESermonix Pharmaceuticals to Share Longer Patient Follow-up..

Dernières Valeurs Consultées

NASDAQ
LGND
Ligand Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés